Prostate Cancer Essentials: Part 2 – Diagnosing and Staging
Learning time:
30 Minutes
Topic:
Awareness
Area of Practice:
Primary Care & Secondary Care
Recommended for:
All Health Professionals
A course providing healthcare professionals with an increased understanding of how prostate cancer is diagnosed.
Learning Objectives
By the end of this course, you will be able to:
Discuss the potential benefits and harms of PSA testing with asymptomatic patients, where there is a concern about their risk of prostate cancer, so that they can make an informed decision based on their individual circumstances (for example, comorbidities) and preferences.
Confidently explain how and why individual benefits of a PSA blood test will be different for each patient.
Provide decision making support to patients at the diagnosis stage, to make decisions that are right for them, based on the outcomes of the investigations undertaken.
If you are involved in the treatment of prostate cancer, the course provides an opportunity to increase awareness of the patient journey at this diagnostic phase and enhance understanding of the different stages of prostate cancer that are seen in practice.
Course Author
CatherineHolborn|Senior Lecturer in Radiotherapy & Oncology at Sheffield Hallam University and Training & Education Lead Advanced Wellbeing Research Centre (AWRC)|
National Prostate Cancer Audit: State of the Nation Report 2025
Many men across England may not be receiving recommended combination treatment strategies (treatment intensification) for their metastatic prostate cancer. Black men and men from more socioeconomic backgrounds are less likely to receive appropriate treatment compared to White men and men from less socioeconomic backgrounds.
Nick Ridgman, Head of Support Services at Prostate Cancer UK, is joined by Robin Porter and Anthony Francis, patients with lived experience, to discuss missing recurrences after prostatectomy.